Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Finch Therapeutics Group, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 17 | 11 | −6 |
| Shares | 209.2K | 129.1K | −80.0K (−38.3%) |
| Value | $754.7K | $338.2K | −$416.5K (−55.2%) |
New holders (0)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (6)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Baupost Group LLCSuperinvestorBaupost Group | 67,296 | $243.0K |
| Renaissance Technologies LLC | 11,746 | $42.0K |
| Northwestern Mutual Wealth Management Co | 141 | $509 |
| Bank of America Corp | 12 | $43 |
| Moisand Fitzgerald Tamayo, LLC | 3 | $11 |
| Cutler Group LP | 3 | $0 |